Medicinal Cannabis Industry Australia is excited to announce its expanded board, which is poised to develop the organisation’s renewed strategic directions in early 2025.
The Board comprises:
- Ean Alexander, Altum
- Matt Cantelo, ANTG
- Geoff Cockerill, Vitura
- Peter Crock, Independent
- Justin Howden, Corporate Affairs Advisory
- Carol Ireland, Epilepsy Action Australia
- Phoebe Macleod, Heyday Medical
- Jo Patterson, BOD Science
- Kristin Viccars, MedReleaf Australia
As we move through this critical phase in early 2025, Carol Ireland has been appointed to chair the Board. With her exceptional governance and leadership skills, and extensive experience with MCIA, Carol is well positioned to steer the Board through this pivotal phase of strategic planning and development.
Carol has been at the forefront of the medicinal cannabis movement in Australia. She has had significant contact with people faced with managing very challenging forms of medication-resistant epilepsy, with few or no conventional options left, and she is well known to many in the industry.
The Board will engage its key stakeholders in formulating the new plan, and following its development will consider the structure and resourcing of the organisation to ensure it can achieve its objectives. The Board affirms its commitment to representing the mutual interests of members and stakeholders to build a professional industry based on legitimacy, credibility, and recognition for the Australia sector in domestic and international arenas.
– ENDS –
Download the DOC of this Media Release
Download the PDF of this Media Release
MCIA Media Contact:
Patty Holmes, Executive Officer, MCIA
secretariat@mcia.org.au / 0426 711 114
About MCIA:
MCIA is the peak industry organization and voice for Australia’s medicinal cannabis industry. MCIA’s focus is on building a legitimate industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. MCIA provides stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community, and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.
About ACannabis:
ACannabis Conference and Exhibition is hosted annually by MCIA. Covering cultivation, manufacturing, products and patients, the conference examines innovations in research, compliance, regulations, education, and technology. ACannabis brings together participants from across the medicinal cannabis ecosystem, including policy makers, regulators, researchers, global leaders, healthcare professionals, patients and industry participants.